We are live on ! Find out more
MG

Meditor Group Portfolio holdings

AUM $48.1M
1-Year Est. Return 38.67%
This Fund
S&P 500
This Quarter Est. Return
+11.53%
1 Year Est. Return
+38.67%
3 Year Est. Return
+41.15%
5 Year Est. Return
+72.2%
10 Year Est. Return
+1,065.64%
AUM
$77.1M
AUM Growth
-$38M
Cap. Flow
-$49.1M
Cap. Flow %
-63.59%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
4
Closed

Top Buys

No buys this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 93.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXEL icon
1
Exelixis
EXEL
$13.9B
$68.6M 88.89%
3,138,200
-1,997,558
-39% -$41.8M
ESPR
2
DELISTED
Esperion Therapeutics
ESPR
$3.72M 4.82%
3,791,300
-611,673
-14% -$885K
INDA icon
3
iShares MSCI India ETF
INDA
$6.71B
$2.63M 3.41%
59,400
-69,800
-54% -$3.09M
EPI icon
4
WisdomTree India Earnings Fund ETF
EPI
$2.02B
$2.23M 2.89%
60,700
-91,100
-60% -$3.3M

Similar funds

Meditor Group's Q3 2023 Portfolio in Review

As of Q3 2023, Meditor Group held 4 positions worth $77.1M, down 33% from $115M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Meditor Group withdrew a net $49.1M in Q3 2023, reducing 4 holdings. Its largest reduction was Exelixis, cutting an estimated $41.8M.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, up from 91% a quarter earlier.

  • Meditor Group's biggest Q3 2023 reduction was Exelixis, cutting an estimated $41.8M.
  • Meditor Group's ten largest holdings make up 100% of its $77.1M portfolio in Q3 2023.
  • Meditor Group opened 0 new positions and closed 0 in Q3 2023.
  • Meditor Group's portfolio value fell 33% quarter-over-quarter to $77.1M.

Based on Meditor Group's 13F filing for Q3 2023, filed 31 Oct 2023.